Synaptogenix Inc (SNPX)

[runncoach]

Not sure of its status. Signing an MOU to initiate a trial that a children's hospital is going to run isn't something you can just come out and set specific dates on. It's not up to Synaptogenix. We aren't experts in the FragileX field. We have a drug that has a lot of preclinical study on. That's why the trial is projected to be run so inexpensively, because others will run it. True enough it was hoped to begin in the first half of 2022. True enough we have paid an outside contractor to help with the INDs for the 2 new indications. However Dupont or the Cleveland Clinic set up their own protocols and on their own timelines for their doctors and patients will be up to them. Not sure how much the company can say until that is complete. Doesn't make me happy but it is what it is. Hopefully any day day now, but its an indefinite timeline. JMHO